A new report published in Age & Ageing gives updated figures on the prevalence of sarcopenia (muscle dysfunction), and calls for active screening of older adults along with exercise programs to help manage the condition. The systematic review revealed new details around sarcopenia – an important health condition which is associated with an increased risk of falls and functional dependence.
The report shows that sarcopenia may affect as many as 1 in 20 adults, and up to 1 in 3 care home residents. These findings come from an international collaborative study, which uses a new international consensus definition of sarcopenia to draw together all the results from recent cutting-edge research.
The report also reveals that there are successful treatments available to manage the condition. Exercise interventions, including endurance and resistance training, appear to improve muscle strength and function, as do short term nutritional intervention trials using proteins, essential amino acids, leucine or beta-hydroxy beta-methylbutyrate (although evidence from longer-term trials is sparse). Continue reading
David Stott is Professor of Geriatric Medicine at the Institute of Cardiovascular and Medical Sciences at the University of Glasgow and is Editor in Chief for Age and Ageing journal. Here he introduces two case reports from the latest issue of the journal.
The inclusion of case reports in Age and Ageing emphasises the clinical focus of the journal. Typically they illustrate either classic presentations of uncommon diseases or unusual presentations or aspects of common diseases in older people. At their best case reports provide a blueprint for high-quality clinical decision making and health care in ‘tricky’ cases. They often carry general lessons that can be learned from specific challenging circumstances. Case reports are generally valued by our readers, providing clinical education and giving balance to the journal’s content.
In the current issue of the journal we report a case of an unusual infection causing acute neurological deterioration (a stroke mimic), and of a rare but treatable disease, Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalopathy. In both these cases failure to make the diagnosis would likely have carried catastrophic consequences.
In this issue we have a new development, adding a short expert commentary by Tom Hughes (from Cardiff) to the case reports which places them in a wider context, helping to bring the implications of the cases to the fore. Continue reading